Spiriva and PNEUMONIA

7,976 reports of this reaction

3.0% of all Spiriva reports

#6 most reported adverse reaction

Overview

PNEUMONIA is the #6 most commonly reported adverse reaction for Spiriva, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.. There are 7,976 FDA adverse event reports linking Spiriva to PNEUMONIA. This represents approximately 3.0% of all 266,551 adverse event reports for this drug.

Patients taking Spiriva who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PNEUMONIA7,976 of 266,551 reports

PNEUMONIA is a less commonly reported adverse event for Spiriva, but still significant enough to appear in the safety profile.

Other Side Effects of Spiriva

In addition to pneumonia, the following adverse reactions have been reported for Spiriva:

Frequently Asked Questions

Does Spiriva cause PNEUMONIA?

PNEUMONIA has been reported as an adverse event in 7,976 FDA reports for Spiriva. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PNEUMONIA with Spiriva?

PNEUMONIA accounts for approximately 3.0% of all adverse event reports for Spiriva, making it a notable side effect.

What should I do if I experience PNEUMONIA while taking Spiriva?

If you experience pneumonia while taking Spiriva, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.